VIGL - Vigil Neuroscience, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 8.05

Open

$ 8.05

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

-- - --

52 Week Range

$ 1.31 - $ 8.10

Volume

5,506,711

Average Volume

Market Cap

375.71M

Beta (5Y Monthly)

$ 0.78

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	03-13-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	03-26-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-21-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-25-2022	12-31-2021	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

loss-making-russell-2000-stocks-drive-surprise-rally-says-liz-ann-sonders

Loss-Making Russell 2000 Stocks Drive Surp...
10/10/2025 08:27:00

Liz Ann Sonders, the Chief Investment Strategist at Charles Schwab & Co. (NYSE: SCHW) highlighted certain unusual divergenc...

Vigil Neuroscience Q2 EPS $(0.56) Misses $...
08/05/2025 13:37:21

Vigil Neuroscience (NASDAQ:VIGL) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of ...

eli-lillys-early-alzheimers-drug-recommended-for-approval-by-european-drug-regulators-panel

Eli Lilly's Early Alzheimer's Drug Recomme...
07/25/2025 13:27:16

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease prog...

Vigil Neuroscience Discontinues Phase 2 Ex...
06/04/2025 11:16:44

Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia f...

Stifel Downgrades Vigil Neuroscience to Ho...
05/28/2025 16:27:48

Stifel analyst Paul Matteis downgrades Vigil Neuroscience (NASDAQ:VIGL) from Buy to Hold and lowers the price target from $1...

HC Wainwright & Co. Downgrades Vigil Neuro...
05/27/2025 15:25:47

HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience (NASDAQ:VIGL) from Buy to Neutral and lowers the p...

us-stocks-likely-to-open-on-a-mixed-note-nothing-good-happens-above-a-5-yield-says-expert

US Stocks Likely To Open On A Mixed Note: ...
05/23/2025 10:15:19

U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in prema...

nasdaq-gains-over-50-points-following-positive-economic-reports-investor-sentiment-improves-fear-index-remains-in-greed-zone

Nasdaq Gains Over 50 Points Following Posi...
05/23/2025 07:32:31

12 Health Care Stocks Moving In Thursday's...
05/22/2025 17:06:46

dow-moves-higher-us-initial-jobless-claims-fall

Dow Moves Higher; US Initial Jobless Claim...
05/22/2025 16:29:45

JMP Securities Downgrades Vigil Neuroscien...
05/22/2025 14:57:25

JMP Securities analyst Jason Butler downgrades Vigil Neuroscience (NASDAQ:VIGL) from Market Outperform to Market Perform.

nasdaq-gains-over-100-points-bjs-wholesale-earnings-top-views

Nasdaq Gains Over 100 Points; BJ's Wholesa...
05/22/2025 14:15:34

accenture-to-rally-more-than-24-here-are-10-top-analyst-forecasts-for-thursday

Accenture To Rally More Than 24%? Here Are...
05/22/2025 13:21:21

12 Health Care Stocks Moving In Thursday's...
05/22/2025 12:10:00

William Blair Downgrades Vigil Neuroscienc...
05/22/2025 12:03:49

William Blair analyst Myles Minter downgrades Vigil Neuroscience (NASDAQ:VIGL) from Outperform to Market Perform.

This Guidewire Software Analyst Is No Long...
05/22/2025 11:54:41

Wedbush Downgrades Vigil Neuroscience to N...
05/22/2025 11:45:18

Wedbush analyst Laura Chico downgrades Vigil Neuroscience (NASDAQ:VIGL) from Outperform to Neutral and lowers the price targ...

sanofi-boosts-alzheimers-pipeline-with-vigil-neuroscience-acquisition

Sanofi Boosts Alzheimer's Pipeline With Vi...
05/22/2025 11:21:48

Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition exc...

Trading Halt: Halt status updated at 6:55:...
05/22/2025 10:55:06

Reported Earlier, Sanofi To Acquire Vigil ...
05/22/2025 05:43:15

Financial considerationsUnder the terms of the merger agreement, Sanofi and Vigil have agreed to the following:Sanofi will acqu...